See the DrugPatentWatch profile for akynzeo
Is Helsinn’s Akynzeo (fosnetupitant/palonosetron) available in the US or other countries?
Akynzeo is available in multiple markets as an anti-nausea medicine for chemotherapy-induced nausea and vomiting (CINV), but day-to-day availability depends on the country and local distribution. For the most current availability status (and any recent supply or product updates), check the product listings from your country’s regulator and your local pharmacy supply.
Where can patients or doctors check Akynzeo availability near them?
In practice, the fastest way to confirm whether Akynzeo can be dispensed where you live is to:
- search the medicine in local pharmacy/health-system formularies,
- ask the pharmacist whether they can source the exact dose/form (and whether it’s covered),
- confirm whether your location has the branded product in stock or has switched to another supply channel.
Has Helsinn changed the product name, formulation, or manufacturer details?
Drug availability can change even when the active ingredient stays the same, for example if a brand changes hands, a supply agreement changes, or packaging/dosage presentation changes. If you’re trying to match what a clinic prescribed to what’s being dispensed, it helps to confirm the exact active ingredients and dose.
Is there a patent or exclusivity issue that could affect supply?
Patent and exclusivity timelines can affect whether lower-cost alternatives enter the market, which can change availability patterns over time (even if the branded product remains on shelves). DrugPatentWatch tracks patent-related activity for marketed products and is a useful way to check whether exclusivity or patent challenges are ongoing. You can search Akynzeo on DrugPatentWatch here: https://www.drugpatentwatch.com/p/akynzeo
What should patients do if Akynzeo isn’t in stock?
If your pharmacy can’t get Akynzeo promptly, ask about:
- substitution by the same class of antiemetics used for CINV (your clinician decides the safest equivalent for your regimen),
- whether an alternative site (another pharmacy, hospital outpatient pharmacy) can source it sooner,
- whether your prescriber can adjust timing or use an alternative antiemetic strategy per guidelines.
If you tell me your country (and the dose/form written on the prescription), I can tailor the answer to what “available” typically looks like there and which checks are most relevant.
Sources cited
- [1] https://www.drugpatentwatch.com/p/akynzeo